7.371 Biological and Engineering Principles Underlying Novel Biotherapeutics


Class Info

Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and immune cells. Special attention to monoclonal antibodies and engineered immune system cells as therapeutics; protein- and glyco- engineering to enhance protein function; protein pharmacology and delivery; nucleic acid- based biotherapeutics; generation of functional cells and tissues from embryonic stem cells and iPS cells; and immune cell-cancer cell interactions in cancer immunotherapy.

This class has 7.06 as a prerequisite.

7.371 will be offered this semester (Fall 2017). It is instructed by J. Chen and H. Lodish.

Lecture occurs 3:00 PM to 5:00 PM on Mondays and Wednesdays in WI-7TH.

This class counts for a total of 12 credits.

You can find more information at the http://www.google.com/search?&q=MIT+%2B+7.371&btnG=Google+Search&inurl=https site or on the 7.371 Stellar site.

Required Textbooks
Save up to up to 27% by purchasing through MIT Textbooks!
MIT 7.371 Biological and Engineering Principles Underlying Novel Biotherapeutics Related Textbooks
MIT 7.371 Biological and Engineering Principles Underlying Novel Biotherapeutics On The Web

© Copyright 2015